Callodine Capital Management LP Has $9.62 Million Stock Holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Callodine Capital Management LP raised its position in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 25.0% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,030,882 shares of the pharmacy operator’s stock after purchasing an additional 205,882 shares during the period. Walgreens Boots Alliance makes up approximately 2.0% of Callodine Capital Management LP’s investment portfolio, making the stock its 18th biggest position. Callodine Capital Management LP owned 0.12% of Walgreens Boots Alliance worth $9,618,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in WBA. First Financial Corp IN increased its position in Walgreens Boots Alliance by 49.2% during the 4th quarter. First Financial Corp IN now owns 2,685 shares of the pharmacy operator’s stock worth $25,000 after purchasing an additional 885 shares in the last quarter. Golden State Wealth Management LLC acquired a new position in shares of Walgreens Boots Alliance during the fourth quarter worth $26,000. Riverview Trust Co lifted its stake in shares of Walgreens Boots Alliance by 123.8% in the 4th quarter. Riverview Trust Co now owns 2,874 shares of the pharmacy operator’s stock valued at $27,000 after acquiring an additional 1,590 shares during the last quarter. Venturi Wealth Management LLC acquired a new stake in shares of Walgreens Boots Alliance during the 4th quarter valued at $28,000. Finally, Independence Bank of Kentucky bought a new stake in Walgreens Boots Alliance during the 4th quarter worth $39,000. 58.59% of the stock is currently owned by institutional investors.

Walgreens Boots Alliance Price Performance

Shares of WBA opened at $10.89 on Friday. The firm has a market cap of $9.42 billion, a PE ratio of -1.06, a price-to-earnings-growth ratio of 1.31 and a beta of 0.67. Walgreens Boots Alliance, Inc. has a 52-week low of $8.08 and a 52-week high of $18.83. The business’s 50 day moving average price is $10.82 and its two-hundred day moving average price is $10.12. The company has a debt-to-equity ratio of 0.68, a quick ratio of 0.30 and a current ratio of 0.64.

Walgreens Boots Alliance (NASDAQ:WBA) last issued its earnings results on Tuesday, April 8th. The pharmacy operator reported $0.63 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.53 by $0.10. Walgreens Boots Alliance had a negative net margin of 5.87% and a positive return on equity of 17.61%. The business had revenue of $38.59 billion for the quarter, compared to analyst estimates of $37.90 billion. During the same period in the prior year, the firm earned $1.20 earnings per share. Walgreens Boots Alliance’s revenue was up 4.1% on a year-over-year basis. On average, equities analysts anticipate that Walgreens Boots Alliance, Inc. will post 1.6 EPS for the current year.

Wall Street Analyst Weigh In

A number of analysts have recently commented on the company. StockNews.com initiated coverage on Walgreens Boots Alliance in a research note on Friday, April 11th. They set a “hold” rating on the stock. Truist Financial decreased their price target on shares of Walgreens Boots Alliance from $13.00 to $12.00 and set a “hold” rating for the company in a research report on Friday, January 31st. Wolfe Research upgraded shares of Walgreens Boots Alliance to a “hold” rating in a report on Monday, February 24th. Deutsche Bank Aktiengesellschaft downgraded Walgreens Boots Alliance from a “hold” rating to a “sell” rating and decreased their price objective for the company from $11.00 to $9.00 in a report on Friday, February 28th. Finally, Bank of America lifted their target price on Walgreens Boots Alliance from $7.50 to $8.50 and gave the stock an “underperform” rating in a report on Monday, January 13th. Four analysts have rated the stock with a sell rating, seven have given a hold rating and two have assigned a buy rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus price target of $10.59.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.